StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$34.39−0.40 (-1.15%)

Close on Nov 17, 2026Market cap $2.27BP/E 6.4Yield –

Lakefront Biotherapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Lakefront Biotherapeutics's pe ratio was 6.1× on Nov 11, 2026, against 24.1× a year earlier. Over the last 5 years it ranged from 4.9× to 83.4×, with a median of 24.9×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20266.1×−18.7
2025Dec 31, 202524.9×+16.6
2024Dec 31, 20248.3×−19.2
2021Feb 26, 202127.4×−5.1
2020Dec 31, 202032.5×−42.4
2018Feb 28, 201874.9×+6.4
2017Dec 29, 201768.4×–

More Lakefront Biotherapeutics figures

See a number that looks wrong?